African vs. Caucasian and Asian difference for the association of interleukin-10 promotor polymorphisms with type 2 diabetes mellitus (a meta-analysis study)

Meta Gene

Volumn 9, Issue , 2016, Pages 10-17

  Tarabay, Mohammad ^a   Elshazli, Rami ^b   Settin, Ahmad ^a  

^a MANSOURA UNIVERSITY CHILDREN S HOSPITAL   (Egypt)

^b Damanhour University   (Egypt)

Author keywords

Gene; IL 10; Meta analysis; Polymorphism; T2DM

Indexed keywords

INTERLEUKIN 10;

AFRICAN; ARTICLE; ASIAN; CAUCASIAN; COMPUTER PROGRAM; DISEASE PREDISPOSITION; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HUMAN; META ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PUBLISHING;

EID: 84961151236     PISSN: None     EISSN: 22145400     Source Type: Journal    
DOI: 10.1016/j.mgene.2016.02.006     Document Type: Article

References (34)

1. Arababadi M.K., Reza Mirzaei M., Ali Sajadi S.M., Hassanshahi G., Ahmadabadi B.N., Salehabadi V.A., Derakhshan R., Kennedy D. Interleukin (IL)-10 gene polymorphisms are associated with type 2 diabetes with and without nephropathy: a study of patients from the southeast region of Iran. Inflammation 2012, Jun, 35(3):797-802.
2. Babel N., Gabdrakhmanova L., Hammer M.H., Schoenemann C., Skrypnikov V., Poliak N., Volk H.D., Reinke P. Predictive value of cytokine gene polymorphisms for the development of end-stage renal disease. J. Nephrol. 2006, Nov-Dec, 19(6):802-807.
3. Bai H., Jing D., Guo A., Yin S. Association between interleukin 10 gene polymorphisms and risk of type 2 diabetes mellitus in a Chinese population. J. Int. Med. Res. 2014, Jun, 42(3):702-710.
4. Brooks M.V., Leake A., Parsons C., Pham V. A review of the literature: evaluating dietary intake of Filipino Americans at risk for type 2 diabetes. Nurs. Forum 2012, 47:27-33.
5. Chang Y.H., Huang C.N., Wu C.Y., Shiau M.Y. Association of interleukin-10 A-592C and T-819C polymorphisms with type 2 diabetes mellitus. Hum. Immunol. 2005, Dec, 66(12):1258-1263.
6. Del Prete G., De Carli M., Almerigogna F., Giudizi M.G., Biagiotti R., Romagnani S. Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J. Immunol. 1993, Jan 15, 150(2):353-360.
7. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control. Clin. Trials 1986, Sep, 7(3):177-188.
8. Egger M., Smith G.D., Phillips A.N. Meta-analysis: principles and procedures. BMJ 1997, Dec 6, 315(7121):1533-1537.
9. Erdogan M., Cetinkalp S., Ozgen A.G., Saygili F., Berdeli A., Yilmaz C. Interleukin-10 (-1082G/A) gene polymorphism in patients with type 2 diabetes with and without nephropathy. Genet. Test. Mol. Biomarkers 2012, Feb, 16(2):91-94.
10. Eskdale J., Kube D., Tesch H., Gallagher G. Mapping of the human IL10 gene and further characterization of the 5' flanking sequence. Immunogenetics 1997, 46:120-128.
11. Forte G.I., Pilato G., Vaccarino L., Sanacore M., Candore G., Romano G.C., Testa R., Franceschi C., Capri M., Marra M., Bonfigli A.R., Caruso C., Scola L., Lio D. Risk profiles in type 2 diabetes (metabolic syndrome): integration of IL-10 polymorphisms and laboratory parameters to identify vascular damages related complications. Curr. Pharm. Des. 2010, 16(7):898-903.
12. García-Elorriaga G., Vera-Ramírez L., del Rey-Pineda G., González-Bonilla C. 592 and -1082 interleukin-10 polymorphisms in pulmonary tuberculosis with type 2 diabetes. Asian Pac. J. Trop. Med. 2013, Jul, 6(7):505-509.
13. Helaly M.A., Hatata E.Z., El-magd M.A., Ibrahem E.F., Al Said A., Abd el-aal I.A., Settin A.S. Association of IL-10 and IL-6 gene polymorphisms with type 2 diabetes mellitus among Egyptian patients. Eur. J. Gen. Med. 2013, 10:158-162.
14. Higgins J.P., Thompson S.G. Quantifying heterogeneity in a meta-analysis. Stat. Med. 2002, Jun 15, 21(11):1539-1558.
15. Hua Y., Shen J., Song Y., Xing Y., Ye X. Interleukin-10 -592C/A, -819C/T and -1082A/G polymorphisms with risk of type 2 diabetes mellitus: a HuGE review and meta-analysis. PLoS ONE 2013, Jun 21, 8(6).
16. Kilpinen S., Huhtala H., Hurme M. The combination of the interleukin-1alpha (IL-1alpha-889) genotype and the interleukin-10 (IL-10 ATA) haplotype is associated with increased interleukin-10 (IL-10) plasma levels in healthy individuals. Eur. Cytokine Netw. 2002, 13(1):66-71.
17. Kolla V.K., Madhavi G., Pulla Reddy B., SrikanthBabu B.M., Yashovanthi J., Valluri V.L., Ramesh J., Akka J. Association of tumor necrosis factor alpha, interferon gamma and interleukin 10 gene polymorphisms with peripheral neuropathy in South Indian patients with type 2 diabetes. Cytokine 2009, 47(3):173-177.
18. Kramer C.K., Zinman B., Choi H., Retnakaran R. Effect of short-term intensive insulin therapy on post-challenge hyperglucagonemia in early type 2 diabetes. J. Clin. Endocrinol. Metab. 2015, 100(8):2987-2995.
19. Kung W.J., Lin C.C., Liu S.H., Chaung H.C. Association of interleukin-10 polymorphisms with cytokines in type 2 diabetic nephropathy. Diabetes Technol. Ther. 2010, 12:809-813.
20. Li J., Wu S., Wang M.R., Wang T.T., Zhu J.M. Association of the interleukin-10 -592A/C, -1082G/A and -819T/C gene polymorphisms with type 2 diabetes: a meta-analysis. Gene 2013, 521(2):211-216.
21. Lin J.D., Hsia T.L., Wu C.Z., Su C.C., Ma W.Y., Hsieh A.T., Hsieh C.H., Wang K., Chu Y.M., Pei D. The first and second phase of insulin secretion in naive Chinese type 2 diabetes mellitus. Metabolism 2010, 59(6):780-786.
22. Mantel N., Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J. Natl. Cancer Inst. 1959, 22(4):719-748.
23. Moher D., Liberati A., Tetzlaff J., DG Altman, PRISMA Group Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int. J. Surg. 2010, 8(5):336-341.
24. Mtiraoui N., Ezzidi I., Kacem M., Hadj Ben, Mohamed M., chaieb M., AB Haj Jilani, mahjoub T., WY.almawi Predictive value of interleukin-10 promoter genotypes and haplotypes in determining the susceptibility to nephropathy in type 2 diabetes patients. Diabetes Metab. Res. Rev. 2009, 25(1):57-63.
25. Pickup J.C. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 2004, 27(3):813-823.
26. Saxena M., Srivastava N., Banerjee M. Association of IL-6, TNF-α and IL-10 gene polymorphisms with type 2 diabetes mellitus. Mol. Biol. Rep. 2013, 40(11):6271-6279.
27. Scarpelli D., Cardellini M., Andreozzi F., Laratta E., Hribal M.L., Marini M.A., Tassi V., Lauro R., Perticone F., Sesti G. Variants of the interleukin-10 promoter gene are associated with obesity and insulin resistance but not type 2 diabetes in Caucasian Italian subjects. Diabetes 2006, 55(5):1529-1533.
28. Steyn N.P., Lambert E.V., Tabana H. Conference on "Multidisciplinary approaches to nutritional problems". Symposium on "Diabetes and health". Nutrition interventions for the prevention of type 2 diabetes. Proc. Nutr. Soc. 2009, 68(1):70-55.
29. Tsiavou A., Hatziagelaki E., Chaidaroglou A., Manginas A., Koniavitou K., Degiannis D., Raptis S.A. TNF-alpha, TGF-beta1, IL-10, IL-6, gene polymorphisms in latent autoimmune diabetes of adults (LADA) and type 2 diabetes mellitus. J. Clin. Immunol. 2004, 24(6):591-599.
30. van Exel E., Gussekloo J., de Craen A.J., Frölich M., Der Wiel A Bootsma-Van, RG westendorp Leiden 85 plus study. low production capacity of interleukin-10 associates with the metabolic syndrome and type 2 diabetes: the Leiden 85-plus study. Diabetes 2002, 51(4):1088-1092.
31. Wang J.D., Fang H., Yan Q.Z., Zhou D.H., Yao H.J. Relationship of serum interleukin-10 level and its gene promoter 592 polymorphism to type 2 diabetes mellitus. Chin. Gen. Pract. 2010, 13:1185-1188.
32. Yin Y.W., Hu A.M., Sun Q.Q., Zhang B.B., Liu H.L., Wang Q., Zeng Y.H., Xu R.J., Zhang S.J., Shi L.B. Association between interleukin 10 gene -1082 A/G polymorphism and the risk of type 2 diabetes mellitus: a meta-analysis of 4250 subjects. Cytokine 2013, 62(2):226-231.
33. Yin Y.W., Sun Q.Q., Zhang B.B., Hu A.M., Liu H.L., Wang Q., Zeng Y.H., Xu R.J., Ma J.B., Shi L.B. Association between interleukin-10 gene -592 C/A polymorphism and the risk of type 2 diabetes mellitus: a meta-analysis of 5320 subjects. Hum. Immunol. 2012, 73:960-965.
34. Zhang F., Yang Y., Lei H., Qiu J., Wang Y., Hu D., Skrip L., Chen F. A meta-analysis about the association between -1082G/A and -819C/T polymorphisms of IL-10 gene and risk of type 2 diabetes. Hum. Immunol. 2013, 74(5):618-626.